Skip to Content
Merck
CN
All Photos(1)

Key Documents

Safety Information

Y0001556

Ciclesonide impurity C

European Pharmacopoeia (EP) Reference Standard

Sign Into View Organizational & Contract Pricing

Select a Size

1 KG
CN¥1,198.93
3 X 1 KG
CN¥3,027.27
5 KG
CN¥3,852.17
12 KG
CN¥9,202.72
25 KG
CN¥12,080.83

CN¥1,198.93

Estimated to ship onApril 11, 2025Details

Request a Bulk Order
All Photos(1)

Select a Size

Change View
1 KG
CN¥1,198.93
3 X 1 KG
CN¥3,027.27
5 KG
CN¥3,852.17
12 KG
CN¥9,202.72
25 KG
CN¥12,080.83

About This Item

UNSPSC Code:
41116107
NACRES:
NA.24

CN¥1,198.93

Estimated to ship onApril 11, 2025Details

Request a Bulk Order

biological source

synthetic

grade

pharmaceutical primary standard

Agency

EP

API family

ciclesonide

form

powder

packaging

pkg of 10 mg

manufacturer/tradename

EDQM

storage condition

protect from light

solubility

water: <0.1 g/L

application(s)

pharmaceutical (small molecule)

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
NA0150NA0200NA0150S
GenElute&#8482; HP Plasmid Miniprep Kit sufficient for 350&#160;preparations

NA0160

GenElute™ HP Plasmid Miniprep Kit

GenElute&#8482; HP Plasmid Miniprep Kit sufficient for 70&#160;preparations

NA0150

GenElute™ HP Plasmid Miniprep Kit

GenElute&#8482; HP Plasmid Midiprep Kit sufficient for 25&#160;purifications

NA0200

GenElute™ HP Plasmid Midiprep Kit

GenElute&#8482; HP Plasmid Miniprep Kit sufficient for 10&#160;preparations

NA0150S

GenElute™ HP Plasmid Miniprep Kit

usage

sufficient for 350 preparations

usage

sufficient for 70 preparations

usage

sufficient for 25 purifications

usage

sufficient for 10 preparations

greener alternative product characteristics

Designing Safer Chemicals
Learn more about the Principles of Green Chemistry.

greener alternative product characteristics

Designing Safer Chemicals
Learn more about the Principles of Green Chemistry.

greener alternative product characteristics

Designing Safer Chemicals
Learn more about the Principles of Green Chemistry.

greener alternative product characteristics

-

sustainability

Greener Alternative Product

sustainability

Greener Alternative Product

sustainability

Greener Alternative Product

sustainability

-

NA0150

NA0150S, NA0160, NA9604

NA0200S

NA0150, NA0160, NA9604

greener alternative category

Aligned,

greener alternative category

Aligned,

greener alternative category

, Aligned

greener alternative category

-

General description

Ciclesonide impurity C is an impurity of ciclesonide, which is a new-generation, non-halogenated glucocorticoid.[1][2][3]
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ciclesonide impurity C is used as a EP reference standard to quantify the analyte in pharmaceutical formulations using liquid chromatography (LC) technique.[4]

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

监管及禁止进口产品

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    New Drugs for Asthma, Allergy and COPD (2001)
    Ciclesonide
    European Pharmacopoeia Commission and European Directorate for the Quality of Medicines & Healthcare
    European pharmacopoeia, 10.3 (2017)
    Ruediger Nave et al.
    Clinical pharmacokinetics, 43(7), 479-486 (2004-05-14)
    Ciclesonide is a novel inhaled corticosteroid developed for the treatment of asthma. To investigate the extent of oral absorption and bioavailability of ciclesonide referenced to an intravenous infusion. This information provides an estimate for the contribution of the swallowed fraction
    Pharmacokinetics of [14 C] ciclesonide after oral and intravenous administration to healthy subjects
    Nave R, et al.
    Clinical Pharmacokinetics, 43, 479-486 (2004)
    Rethinking Cleaning Validation for API Manufacturing
    Zhang C, et al.
    Pharmaceutical Technology, 42, 42-54 (2018)

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service